Enfermedad meningocócica: nuevas estrategias de prevención

Soult Rubio, J.A.; Muñoz Sáez, M.; López Castilla, J.D.

doi:10.1016/S1695-4033(01)78651-1

Anales de Pediatría (English Edition)

ISSN: 2341-2879

The Spanish Pediatric Association (Asociación Española de Pediatría, AEP) has as one of its main objectives the dissemination of rigorous and up-to-date scientific information on the various areas of pediatrics. Annals of Pediatrics is an open access journal that serves as the Association's Scientific Expression Organ and constitutes the vehicle through which members communicate. Annals of Pediatrics publishes, in English and Spanish, original research papers on pediatrics, as well as review articles prepared by experts in each specialty, and guidelines or positioning documents prepared by the different Societies/Specialized Sections integrated into the Spanish Pediatric Association. The journal, a reference for Spanish-speaking pediatrics, is indexed in the most important international databases: Index Medicus/Medline IBECS, IME, SCOPUS, Science Citation Index Expanded, Journal Citations Report, Embase/Excerpta Medica, Directory of Open Access Journals (DOAJ).

Indexed in:

Index Medicus/Medline IBECS, IME, SCOPUS, Science Citation Index Expanded, Journal Citations Report, Embase/Excerpta Medica, Directory of Open Access Journals (DOAJ)

La vacuna conjugada frente a meningococo C supone un extraordinario avance en las medidas de prevención de esta enfermedad y justifica que se revisen las recomendaciones de vacunación actualmente aceptadas. Las autoridades sanitarias son las responsables de realizar una estrecha vigilancia epidemiológica y valorar la necesidad de establecer campañas de vacunación de la población. Esta actuación sanitaria debe incluir a todos los grupos de población en riesgo de presentar la enfermedad y asegurar la correcta y duradera protección de los niños vacunados.

Palabras clave:

nfermedad meningocócica

Vacuna conjugada

Because conjugate C meningococcal vaccines represent a significant advance in the prevention of meningococcal disease, currently accepted recommendations on vaccination should be revised. The health authorities are responsible for carrying out national surveillance programs and for evaluating the need for vaccination programs. These programs should target all groups at risk for this disease and should confer adequate and lasting protection in vaccinated children.

Key words:

eningococcal disease

Conjugate vaccines

Full text is only aviable in PDF

Bibliogrífia

[1.]

E.A. Kirsch, R.P. Barton, L. Kitcahen, B.P. Giroir.

Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience.

Pediatr Infect Dis, 15 (1996), pp. 967-979

[2.]

A. Leach, P.A. Twumasi, S. Kumah, W. Banya, S. Jaffar, B. Forrest, et al.

Induction of inmunologic memory in gambian chidren by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.

J Infect Dis, 175 (1997), pp. 200-204

Medline

[3.]

G. Campagne, A. Garba, P. Fabre, A. Schuchat, R. Ryall, D. Boulanger, et al.

Safety and inmunogenicity of three doses of a Neisseria meningitidis A + C conjugate vaccine in infants from Niger.

Pediatr Infect Dis J, 19 (2000), pp. 144-150

Medline

[4.]

P. Richmond, R. Borrow, F. Miller, S. Clark, F. Sadler, A. Foz, et al.

Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.

J Infect Dis, 179 (1999), pp. 1569-1572

http://dx.doi.org/10.1086/314753 | Medline

[5.]

J.L. Aboal, P. Farjas, R. Zubizarreta, X. Hervada, A. Malvar, M. Amigo, et al.

Meningococcal C disease epidemic in Galicia 1996: the decision making process.

Gac Sanit, 13 (1999), pp. 62-69

Medline

[6.]

J.A. Soult, M. Fernández, M. Muñoz, M. Barrera, J.D. López, A. Tovaruela.

Aumento en la incidencia de enfermedad meningocócica por serogrupo C en la provincia de Sevilla.

An Esp Pediatr, 47 (1997), pp. 659-660

Medline

[7.]

B. Schwartz, A. Al-Tobaiqi, A. Al-Ruwais.

Comparative efficacy of ceftriaxone and rifampin in eradicating pharyngeal carriage of group A Neisseria meningitidis.

Lancet, 2 (1988), pp. 1239-1242

Medline

[8.]

M.C. Pearce, J.W. Sheridan, D.M. Jones, G.W. Lawrence, D.M. Murphy, B. Massuti, et al.

Control of group C meningococcal disease in australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination.

Lancet, 346 (1995), pp. 20-23

Medline

[9.]

L.A. Mitchell, J.J. Ochnio, C. Glover, A.Y. Lee, M.K. Ho, A. Bell.

Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents.

J Infect Dis, 173 (1996), pp. 1009-1013

Medline

[10.]

N. Rosenstein, O. Levine, J. Taylor, D. Evans, B.D. Plikaytis, J.D. Wenger, et al.

Efficacy of meningococcal vaccine and barriers to vaccination.

JAMA, 279 (1998), pp. 435-439

Medline

[11.]

Advisory Committee on Inmunization Practices (ACIP).

Prevention and control of meningococcal disease.

MMWR, 49 (2000), pp. 1-10

Medline

[12.]

J. McLennan, S. Obaro, J. Deeks, D. Williams, L. Pais, G. Carlone, et al.

Inmune response to revaccination with meningococcal A and C polysaccharides in gambian children following repeated inmunisation during early childhood.

Vaccine, 17 (1999), pp. 3086-3093

Medline

[13.]

D. Granoff, R. Gupta, R. Belshe, E. Anderson.

Induction of inmunologic refractoriness in adults by meningococcal C polysaccharide vaccination.

J Infect Dis, 178 (1998), pp. 870-874

Medline

[14.]

P. Richmond, E. Kacmarski, R. Borrow, J. Findlow, S. Clark, R. McCann, et al.

Meningococcal C polysaccharide vaccine induces inmunologic hiporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.

J Infect Dis, 819 (2000), pp. 761-764

[15.]